Pregnancy-induced hypertension syndrome preventive or therapeutic agents, placental formation promoters or improvers, and agents to enhance adaptability during pregnancy.
TW202637138APending Publication Date: 2026-09-16TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114146819
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-29
- Filing Date
- 2025-12-01
- Publication Date
- 2026-09-16
Smart Images

Figure TWG2TA001076577_001 
Figure TWG2TA001076577_002 
Figure TWG2TA001076577_003
Abstract
This invention provides an agent capable of preventing or treating pregnancy-induced hypertension syndrome. The agent prepared according to this invention contains an effective amount of one or more selected from the group consisting of pyrroloquinoline quinone, pyrroloquinoline quinone salts, apple polyphenols, black rice, and black rice extract.
Need to check novelty before this filing date? Find Prior Art
